Infection Control

Low-dose Dexamethasone Premedication May Be Preferred for Weekly Docetaxel Regimens

Low-dose Dexamethasone Premedication May Be Preferred for Weekly Docetaxel Regimens

By

Low-dose dexamethasone may be preferred as a premedication protocol for patients receiving weekly docetaxel regimens due a significantly lower risk of infection compared with a higher dose regimen.

Central Venous Catheter Self-management Education Program Effective

Central Venous Catheter Self-management Education Program Effective

By

A central venous catheter self-management education program is an effective nursing intervention to promote long-term self-management of a CVC for discharged patients with cancer.

Innovations Reduce Catheter Associated Urinary Tract Infection Rates at an Oncology Hospital

Innovations Reduce Catheter Associated Urinary Tract Infection Rates at an Oncology Hospital

By

The formation of a multidisplinary taskforce and the introduction of improved products successfully reduced the rates of catheter associated urinary tract infections (CAUTI) at an oncology hospital.

Daily Chlorhexidine Gluconate Bathing Reduces CLABSI Rates

Daily Chlorhexidine Gluconate Bathing Reduces CLABSI Rates

By

Daily chlorhexidine gluconate bathing on all patients with ports and tunneled catheters decreased the rates of CLABSI on an inpatient oncology unit.

Antibiotic Prophylaxis During Induction Phase Reduces Infections in Pediatric ALL

Antibiotic Prophylaxis During Induction Phase Reduces Infections in Pediatric ALL

By

Continuous antibiotic treatment can reduce infections in young patients with acute lymphoblastic leukemia (ALL).

UV Light Robots Cut C. Difficile Transmissions by 25% on Cancer Patient Floors

By

New research from infection control specialists found that UV robots helped reduce transmission rates of Clostridium difficile. The intervention also saved approximately $150,000 in annual direct medical costs.

Innovative program helps combat catheter-associated urinary tract infections (CAUTI)

Innovative program helps combat catheter-associated urinary tract infections (CAUTI)

By

Oncology nurses at a New York cancer center successfully reduced the rate of CAUTIs at their facility to zero with a novel program that gives nurses autonomy in making care decisions for patients with urinary catheters.

Multiple biopsies increase infection risk for prostate cancer patients

Multiple biopsies increase infection risk for prostate cancer patients

Men with prostate cancer on active surveillance should be informed of the risk of complications linked to repeated biopsies.

Rate of hospital infections in cancer patients has increased but deaths have declined

By

A nationwide study on patient outcomes after cancer surgeries found that while infections during hospital stays increased during a 10-year period, the death rate from those infections declined.

Preparing for bacteria in cancer patients may help hospitals fight infections

By

Knowing what cancerous conditions lead to which kinds of bacterial infections can help doctors predict which patients are likely to benefit from pretreatment with certain kinds of antibiotics.

Mathematical model may reduce infections from chemotherapy

By

A new mathematical model suggests that proper risk assessment for the risk of infection with cancer chemotherapy needs to evaluate both the quantity and quality of white blood cells. The model was built by Weizmann Institute mathematicians in collaboration with physicians from the Meir Medical Center in Kfar Saba and from the Hoffman-La Roche research center in Basel, Switzerland.

Best practices reduce CBSIs in children with cancer

By

In a prospective, interrupted time series study, a best-practice bundle was used to address all areas of central-line care including reducing entries, having aseptic entries, and using aseptic procedures when changing components.

Device comparison trial achieves 0% CR-BSI rate with neutral-pressure connector

Device comparison trial achieves 0% CR-BSI rate with neutral-pressure connector

By

A comprehensive cancer center conducts a device trial comparing two connectors in an effort to improve CRBSI rates at the facility.

CDC focuses on infection prevention

CDC focuses on infection prevention

A new initiative launched by CDC is designed to reduce the risk of life-threatening infection in cancer patients undergoing chemotherapy.

HPV vaccine protects men from anal cancer

A quadrivalent human papillomavirus (HPV) vaccine to prevent anal cancer was shown to be safe and effective in a trial of healthy men who have sex with men.

Animal-assisted therapy program helps radiation therapy outpatients decrease anxiety

The radiation oncology department at Duke University Medical Center, Durham, North Carolina, has instituted an animal-assisted therapy (AAT) program to help outpatients reduce stress, improve mood, and decrease anxiety during their radiation therapy visit, according to a presentation during the Oncology Nursing Society 36th Annual Congress.

Managing viral infections in severely immunocompromised patients

Oncology nurses play a vital role in patient care, including assessment, early recognition of infections, and patient and family education. Providing evidence-based care and education to severely immunocompromised patients requires knowledge about the association between viruses and diseases, the rationale of specific diagnostic tests, and current treatments.

Oncology FBI team helps promote a culture of safety

Monitoring infection rates and introducing interventions to eliminate central line-associated bloodstream infections (CLABSIs), a serious safety concern for hospitalized oncology patients, is one way nursing care can be advanced in complex health care environments that support a culture of safety, according to a presentation at the Oncology Nursing Society 36th Annual Congress.

Changing practice behaviors reduces central line-associated bloodstream infections

The effects of cancer treatment place patients at high risk for central line-associated blood stream infections (CLABSIs), which directly reflect the care provided at the time of insertion and through the lifetime of the central line. These infections are a significant cause of morbidity, mortality, and increased health care costs. These are the findings of a study presented at the Oncology Nursing Society 36th Annual Congress.

Interventions decrease incidence of catheter-related bloodstream infections

An educational intervention designed to reduce catheter-related bloodstream infections (CR-BSIs) resulted in decreased infection rates that were sustained over time, results of a quality improvement process measuring the efficacy of such interventions have shown. Incidence of CR-BSIs in hematology and oncology inpatients are a high-priority concern: severe sepsis related to these infections can result in increased costs, morbidity and mortality, and prolonged hospitalization. The data were presented at the Oncology Nursing Society 36th Annual Congress.

New guidelines seek to prevent IV catheter-related infections

The CDC and the Healthcare Infection Control Practices Advisory Committee have released new guidelines to help eliminate bloodstream infections associated with intravenous catheters.

Nurses' concern for infections grows

Nurses' concern for infections grows

Oncology nurses are concerned about the growing number of invasive fungal infections among their cancer patients, according to a recent report.

Preventing an H1N1 influenza outbreak among cancer patients: One center's success

Preventing an H1N1 influenza outbreak among cancer patients: One center's success

By

The Seattle Cancer Care Alliance proved that aggressive infection control procedures can minimize flu cases in a patient population.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs